Sign in for the best experience.
ORIGINAL RESEARCH
Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer
Modification of Pathologic T Classification for Non-small Cell Lung Cancer With Visceral Pleural Invasion
Breathlessness Predicts Survival in Patients With Malignant Pleural Effusion
EDITORIALS
Malignant Pleural Effusion Management and Breathlessness: A Crystal Ball to Predict Survival Would Be Helpful
Age, Sex, Smoking, and Race: Is Progress Being Made in Lung Cancer Screening Eligibility?
LUNG CANCER SCREENING
Impact of the COVID-19 Pandemic on Volumes and Disparities in Lung Cancer Screening
Potential Disparities by Sex and Race or Ethnicity in Lung Cancer Screening Eligibility Rates
This visual abstract provides key information at a glance from a recent article evaluating the prognostic significance and discriminatory capability of the number of involved nodal stations in non-small cell lung cancer.
Which N Descriptor Is More Predictive of Prognosis in Resected Non-small Cell Lung Cancer: The Number of Involved Nodal Stations or the Location-Based Pathological N Stage?
CHEST JOURNAL | Access even more thoracic oncology research. Read the journal »
Managing Pulmonary Complications From Cancer During the Pandemic and Beyond: Pleural Effusion, Airway Obstruction, and Pneumonitis
Moderator: Septimiu Murgu, MD, FCCP Panelists: Mary Jo Fidler, MD; David Feller-Kopman, MD, FCCP; and Eric Edell, MD, FCCP
Also available:
Get evidence-based information for enhancing patient care with CHEST’s guidelines and consensus statements.
NEW! Screening for Lung Cancer
Evaluation and Management for High-Risk Patients With Stage I Non-small Cell Lung Cancer
Diagnosis and Management of Lung Cancer
ALL THORACIC ONCOLOGY GUIDELINES
The CHEST Foundation’s lung cancer resources empower patients to engage in better management of their health.
Lung Cancer Information for Patients »
Written and peer reviewed by renowned experts in the critical care, pulmonary, and sleep medicine fields, the online CHEST SEEK Library and print publications include case-based questions and detailed rationales to stimulate and challenge your clinical thought processes; help you prepare for certification or recertification exams; and allow you to obtain CME credit, MOC points, and CE hours.
CHEST SEEK LIBRARY | Access hundreds of critical care, pulmonary, and sleep medicine questions. Purchase now »
Stay on the cutting edge of patient care and earn CME credit with learning opportunities available exclusively through CHEST.
Establish your skills identifying and educating eligible persons for annual lung cancer screening and become comfortable suggesting tobacco treatment services to patients.
Learn how to identify lung sliding, lung pulse, A lines, B lines, and consolidation, and get an overview of the transducer manipulation required to obtain high-quality, standard image planes.
These 12 online sessions cover barriers to lung cancer screening, knowledge gaps related to biomarkers, updates in diagnosis and staging, management of oligometastatic disease, and more.
CHEST E-LEARNING LIBRARY | Customize a learning plan specific to your needs. Subscribe today »
Bring your sword of knowledge to the fight in the interactive Game of Nodules, where you will face multiple levels of challenging questions on the management of patients diagnosed with lung nodules. Be quick and accurate in your answer selections, as the player with the highest score attained in the least amount of time will claim the throne!
Start playing now »
By: Max Wayne, MD, and Jose Cardenas-Garcia, MD Thoracic Oncology Network Drs. Wayne and Cardenas-Garcia discuss delays in lung cancer screening and diagnosis during the COVID-19 pandemic.
A group of medical organizations, including CHEST, is holding monthly webinars to update referring clinicians and patients on the new U.S. Preventive Services Task Force lung cancer screening recommendations. Register for upcoming webinars and catch up on those you missed.
LEARN MORE
In this video from CHEST’s Thoracic Oncology Network, Munish Luthra, MD, FCCP; Jarushka Naidoo, MBBCh; and Karthik Suresh, MD, discuss the pulmonary complications of immune checkpoint inhibitors.
If you’re not already a CHEST member, become one today for access to additional resources, discounts on educational activities, and networking opportunities. Join now »